Standard BioTools Inc. (LAB)
NASDAQ: LAB · Real-Time Price · USD
0.9250
+0.0350 (3.93%)
At close: Apr 7, 2026, 4:00 PM EDT
0.9250
0.00 (0.00%)
After-hours: Apr 7, 2026, 4:28 PM EDT

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Medical Products
85.33M91.01M106.34M--
Medical Products Growth
-6.24%-14.42%---
Proteomics
---52.50M67.66M
Proteomics Growth
----22.40%-
Genomics
---45.45M62.92M
Genomics Growth
----27.78%-
Total
85.33M91.01M106.34M97.95M130.58M
Total Growth
-6.24%-14.42%8.57%-24.99%-5.47%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Americas Excl. United States
2.16M2.00M2.10M2.98M3.68M
Americas Excl. United States Growth
8.16%-4.68%-29.71%-18.90%42.19%
Emea Excl. Sweden
27.39M26.55M29.82M--
Emea Excl. Sweden Growth
3.16%-10.97%---
Sweden
8.60M9.10M6.38M--
Sweden Growth
-5.50%42.64%---
United States
28.40M35.40M44.10M41.00M60.20M
United States Growth
-19.77%-19.73%7.56%-31.89%-16.39%
Asia-Pacific (Excl. China)
7.88M7.95M7.99M10.06M11.48M
Asia-Pacific (Excl. China) Growth
-0.84%-0.52%-20.52%-12.42%-21.80%
China
10.90M10.01M15.95M10.77M12.50M
China Growth
8.88%-37.24%48.05%-13.81%12.61%
Europe, Middle East and Africa (EMEA)
---33.14M42.72M
Europe, Middle East and Africa (EMEA) Growth
----22.44%13.09%
Total
85.33M91.01M106.34M97.95M130.58M
Total Growth
-6.24%-14.42%8.57%-24.99%-5.47%
Source: S&P Global Market Intelligence.